Sunday , December 17 2017
Home / Letter From The Editor / Editor’s Note

Editor’s Note

Each week we bring you information about drugs, techniques, studies and education for your patients and we often find that there are certain things we could learn more about. We had our staff do a survey of recent information requests and found that there were a lot of you who wanted to know more about the DPP-4 inhibitors. You wanted to know about how they worked, how they compared to other diabetes medications, and when your colleagues were selecting them.

We have taken all your suggestions and put them together in this Special Edition newsletter focused solely on DPP-4 inhibitors.